Glioblastoma Multiforme Clinical Trials

459 clinical trials for Glioblastoma Multiforme across international registries, including 66 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma — RECRUITING · PHASE2
• Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII — RECRUITING · PHASE2
• The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab — RECRUITING
• Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme — RECRUITING
• Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC) — RECRUITING · PHASE1
• A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment — RECRUITING · PHASE2
• A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM — RECRUITING · PHASE1
• Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma — RECRUITING · PHASE1
• Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma — RECRUITING · PHASE2
• HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors — RECRUITING · PHASE1
• Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors — RECRUITING · PHASE1
• Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning — RECRUITING
• Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion — RECRUITING · PHASE1
• Targeted Pediatric High-Grade Glioma Therapy — RECRUITING
• Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab — RECRUITING · PHASE1
• Loupe-Based Intraoperative Fluorescence Imaging — RECRUITING
• Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial — RECRUITING · NA
• Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA — RECRUITING · PHASE1
• Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM — RECRUITING · PHASE3
• Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM — RECRUITING · PHASE1
• Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma — RECRUITING · NA
• Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM) — RECRUITING · NA
• Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant — RECRUITING · PHASE2
• IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma — RECRUITING · PHASE1
• MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy — RECRUITING
• Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma — RECRUITING · NA
• Sonodynamic Therapy in Patients With Recurrent GBM — RECRUITING · PHASE1
• NK Cell Therapy for Malignant Solid Brain Tumors — RECRUITING · NA
• Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc — RECRUITING · PHASE1
• Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO] — RECRUITING · NA
• A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients — RECRUITING · PHASE3
• Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM) — RECRUITING · PHASE1
• HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM — RECRUITING · PHASE1
• Early Phase Study of KESONOTIDE™in Participants With Solid Tumours — RECRUITING · PHASE1
• Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients — RECRUITING · PHASE2
• 5G-PEARL: Paxalisib in Malignant Brain Tumours — RECRUITING · PHASE1
• Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue — RECRUITING
• Study of Pembrolizumab and M032 (NSC 733972) — RECRUITING · PHASE1
• 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours — RECRUITING · PHASE1
• Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma — RECRUITING · PHASE1
• Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme — RECRUITING · PHASE1
• Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. — RECRUITING · PHASE1
• Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age — RECRUITING · PHASE1
• hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) — RECRUITING · PHASE2
• Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells — RECRUITING · PHASE1
• Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy — RECRUITING · PHASE1
• Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma — RECRUITING · PHASE1
• Allogeneic γδT Cells in Glioblastoma — RECRUITING · NA
• IA Carboplatin + Radiotherapy in Relapsing GBM — RECRUITING · PHASE1
• Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma — RECRUITING · PHASE2

Refine this search